Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin and Misoprostol for Aspirin-Induced Small Bowel Ulcers
NCT03962283Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rifaximin in duodenal ulcer, sponsored by The Chinese University of Hong Kong. Status: unknown.
02
Drugs
rifaximin
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on NCT03962283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962283.